Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

Today, 4:51 PM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP

27 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 4:51 PM

During Tuesday's session, 454 stocks hit new 52-week lows.

ADAG

7 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 4:51 PM

Wednesday's session saw 107 companies set new 52-week lows.

ADAP

2 minute read

67 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:51 PM

Losers

ADAG

3 minute read

42 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 4:51 PM

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development.

AER

1 minute read

Lexicon Pharma Pulls Sotagliflozin US Application Due To Technical Issue, Shares Fall

By Vandana Singh

Today, 4:51 PM

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has

LXRX

1 minute read

Lexicon Pharmaceuticals: Q4 Earnings Insights

By Benzinga Insights

Today, 4:51 PM

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q4 earnings results on Monday, February 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

LXRX

1 minute read

Lexicon Pharmaceuticals Q4 EPS $(0.17) Beats $(0.18) Estimate

By Benzinga Newsdesk

Today, 4:51 PM

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 325 percent decrease over losses of $(0.04) per share

LXRX